$187,000 to $6.30: Turnbull government subsidy gives hope to cancer sufferers

A breakthrough leukaemia and lymphoma drug that normally costs $187,000 per treatment will become easily affordable under a new $460 million Turnbull government subsidy.

Ibrutinib, known as Imbruvica, will cost patients $38.80 a script – or $6.30 for concessional patients – once it is listed on the Pharmaceutical Benefits Scheme from December 1.

The drug will be available to all eligible patients with relapsed or refractory chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).

Prime Minister Malcolm Turnbull will announce the listing on Monday, saying the drug – considered significantly more effective than many of the treatments already available through the PBS – will change lives. Read more… 

Join Our Mailing List